Skip to main content
OpenTrials
Completed

NCT Number: NCT02547571

The Bowel CLEAnsing: A National Initiative

The purpose of this study is to compare diet, type of bowel preparation and time of colonoscopy to determine if one method is better than the other and, if they are the same, identify the one which is the most convenient for the patients.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 4

Primary location

Forzani & MacPhail Colon Cancer Screening Centre, Calgary, Alberta, Canada

Loading trial locations.

About this study

The objective of the current proposed trial is thus to compare the cleanliness achieved with PEG high-volume (2L+2L) split-dose versus PEG (1L+1L)+Bisacodyl low-volume split-dose, or PEG high volume (4L) non-split day before versus PEG low volume (2L) non-split same day preparation, according to time of endoscopy (early or later), as well as assess the role of diet (low residue or clear liquid diet) according to these different Canadian outpatient preparation regimens.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Outpatients
  • 18 years or older
  • Able to comprehend the trial
  • Have an indication for full colonoscopy

Exclusion criteria

Subjects are excluded from enrollment into the study if any of the following are present:

General exclusion criteria:

  • Subject refusal
  • Previous bowel preparation in the last 14 days
  • Pregnancy or breastfeeding
  • Reduced mobility

Medical/Endoscopic exclusion criteria:

  • Suspected or diagnosed with bowel obstruction
  • Any colonic surgery
  • Toxic megacolon
  • Ileus
  • Ischemic colitis
  • Decompensated heart failure
  • Severe acute renal failure
  • Severe liver disease
  • Severe electrolyte imbalance

Treatment and study plan

High volume PEG split-dose

Drug

Colyte® or PegLyte® will be provided to the subject who will be asked to drink 2L of the preparation starting at 7:00 PM the day before the procedure at a rate of 240 mL every 10 minutes until completed. The second dose of 2L of preparation will be taken the morning of the colonoscopy starting 4-5 hours prior to the planned procedural time at a rate of 240 mL every 10 minutes until completed.

Other names: Colyte® or PegLyte®

Low volume PEG split-dose

Drug

Bi-PegLyte® will be provided to the subject who will be asked to ingest 3 tabs of Bisacodyl 5 mg (total 15 mg) at 2:00 PM the day before the procedure. After the first bowel movement, or if there is no bowel movement within 6 hours of taking the Bisacodyl tablets, the subject will be asked to drink 1L of the solution at a rate of 240 mL every 10 minutes until the solution is completed. The second dose of 1L of preparation will be taken the morning of the colonoscopy starting 4-5 hours prior to the procedure at a rate of 240 mL every 10 minutes. Use of antacids will not be permitted within one hour of taking bisacodyl.

Other names: Bi-PegLyte®

High volume PEG non split, day before

Drug

Colyte® or PegLyte® will be provided to the subject who will be asked to drink 4L of preparation starting at 6:00 PM the day before the procedure, at a rate of 240 mL every 10 minutes until completed.

Other names: Colyte® or PegLyte®

Low volume PEG non split, same day

Drug

Bi-PegLyte® will be provided to the subject, who will be asked to ingest 3 tabs of Bisacodyl 5 mg (total 15 mg) at 2:00 PM the day before the procedure and will drink 2L of preparation the morning of the colonoscopy starting 4 hours prior to the procedure at a rate of 240 mL every 10 minutes, until completed. Use of antacids will not be permitted within one hour of taking Bisacodyl.

Other names: Bi-PegLyte®

Clear liquid diet

Other

Low Residue Diet

Other

Early colonoscopy (stratified)

Other

"Early" appointments: 7:30 AM to 10h30 AM

Later colonoscopy (stratified)

Other

"Later" appointments: 10:30 AM to 4:30 PM.

Primary outcomes

  1. Bowel cleansing according to the Boston Scale

    Time frame: Day of colonoscopy

Secondary outcomes

  1. Subject willingness to repeat the preparation (survey)

    Time frame: Day of colonoscopy

  2. Withdrawal time and total procedural time

    Time frame: Day of colonoscopy

  3. Cecal or ileal intubation rate for colonoscopies

    Time frame: Day of colonoscopy

  4. Polyp detection and polypectomy rate

    Time frame: Day of colonoscopy

  5. Right colon polyp detection rate

    Time frame: Day of colonoscopy

  6. Specific lesional rates identified according to pathology

    Time frame: up to 30 days

  7. % of preparation taken by the subject

    Time frame: Day of colonoscopy

  8. Subject travel time to endoscopy unit (hrs)

    Time frame: Day of colonoscopy

  9. Incontinence

    Time frame: Day of colonoscopy

  10. Fecal Immunochemical Test value

    Time frame: Day of colonoscopy

  11. Montreal score compared to BBPS

    Time frame: Day of colonoscopy

  12. Ottawa Bowel Preparation Scores compared to BBPS

    Time frame: Day of colonoscopy

Sponsors and collaborators

Lead sponsor

Alan Barkun

Other

Collaborators

  • Pendopharm

Registry information

Acronym: B-CLEAN

Important dates

Study start
2016
Primary completion
2018
Study completion
2018
First posted
Sep 11, 2015
Registry last updated
Sep 13, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.